In September 2023, the FDA added BPC-157 to its Category 2 list of bulk drug substances under its Interim Policy on Compounding, meaning 503A compounding pharmacies and 503B outsourcing facilities are barred from using it in compounded preparations
Further, clinicians have only recently begun to consider the unique advantages of nasal administration, spurring the development of pharmaceuticals that are highly bioavailable via the nasal mucosa
It is formulated with hydrolysed collagen types 1 and 3 and the reduced active form of glutathione for optimal bioavailability
Benefits include: Accurate dosing Ease of use Reduced discomfort Improved consistency Dosage Recommendations 6 clicks per dose (250mcg) Approximately 40 doses per pen For best results, use consistently alongside proper recovery strategies
Providers may prescribe compounded medications as needed to meet patient requirements
The two catecholamines can also inhibit lipolysis by inhibiting the activation of adenylate cyclase through the 2 -adrenergic receptor